The clinical features, malignant potential, and systemic associations of oral lichen planus: A study of 723 patients

Journal of the American Academy of Dermatology

Volumn 46, Issue 2, 2002, Pages 207-214

  Eisen, Drore ^a  

^a Dermatology Research Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; CANCER RISK; CLINICAL FEATURE; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0036162648     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.120452     Document Type: Article

References (66)

1. Oral lichen planus: A demographic study
2. Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years
3. A clinical study of 205 patients with oral lichen planus
4. A retrospective evaluation of 193 patients with oral lichen planus
5. Clinical characteristics and treatment of patients with oral lichen planus in Israel
6. A prospective follow-up study of 570 patients with oral lichen planus: Persistence, remission, and malignant association
7. Course of various clinical forms of oral lichen planus: A prospective follow-up study of 611 patients
8. Oral lichen planus. 1. A clinical evaluation of 115 cases
9. The evaluation of cutaneous, genital, scalp, nail, esophageal,and ocular involvement in patients with oral lichen planus
10. Immunopathogenesis of oral lichen planus and recurrent aphthous stomatitis
11. Recent advances on the pathogenesis of oral lichen planus (OLP): The adhesion molecules
12. Immunologic aspects of dermal and oral lichen planus: A review
13. VCAM-1 and ICAM-1 are expressed by Langerhans cells, macrophages and endothelial cells in oral lichen planus
14. Enhanced binding of peripheral blood mononuclear leukocytes to gamma-interferon-treated cultured keratinocytes
15. Update on oral lichen planus: Etiopathogenesis and management
16. Assessment of the value of immunofluorescence microscopy in the diagnosis of oral mucosal lichen planus
17. Childhood lichen planus: A report of fifty cases
18. Lichen planus: A simple and reliable biopsy technique
19. Erythroplakic lesions in relation to oral lichen planus
20. Oral lichen planus update: Clinical characteristics, treatment responses, and malignant transformation
21. Lichen planus: Review and update on pathogenesis
22. Oral lichen planus: The clinical, historical, and therapeutic features of 100 cases
23. The sensitivity and specificity of direct immunofluorescence testing in disorders of mucous membranes
24. Direct immunofluorescence in oral lichen planus
25. Isolated lichen planus of the lip
26. Effect of dental plaque control on gingival lichen planus
27. Periodontal status in patients with oral lichen planus: A study of 90 cases
28. Lichen planus evoked by periodontal surgery
29. Psychological factors associated with oral lichen planus
30. Psychologic factors and oral lichen planus: A psychometric evaluation of 100 cases
31. Meeting the educational needs of patients with oral lichen planus
32. Hepatitis C virus infection in Italian patients with oral lichen planus: A prospective case-control study
33. Liver function in UK patients with oral lichen planus
34. Oral lichen planus and chronic liver disease: A clinical and morphometric study of the oral lesions in relation to transaminase elevation
35. Lichen planus and hepatitis C virus: Prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection
36. Preliminary investigation of the association of oral lichen planus and hepatitis C
37. Immunological evaluation in oral lichen planus with chronic hepatitis C
38. Lichen planus and hepatitis C virus: Related chronic active hepatitis
39. Lichen planus is not associated with hepatitis C virus infection in patients from northwest England
40. Oral lichen planus and hepatitis C virus infection: A fortuitous association?
41. Incidence of liver disease in chronic lichen planus of the mouth
42. Lichen planus and liver disease: How strong is the association?
43. Prevalence of hepatitis C virus antibodies and evaluation of hepatitis C virus genotypes in patients with lichen planus
44. A review of the recent literature regarding malignant transformation of oral lichen planus
45. Oral lichen planus: The evidence regarding potential malignant transformation
46. Lichen planus and oral cancer: Is there a connection between the two?
47. Malignant potential of oral lichen planus: Observations in 722 patients from India
48. Malignant potential of oral lichen planus: A follow-up study of 326 patients
49. Oral cancer development in patients with oral lichen planus
50. Interobserver and intraobserver variability in the histologic assessment of oral lichen planus
51. Lichenoid lesions of oral mucosa: Diagnostic criteria and their importance in the alleged relationship to oral cancer
52. Malignant transformation of oral lichen planus
53. Possible mycological etiology of oral mucosal cancer: Catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzyl-methylamine
54. Candida biotypes in patients with oral leukoplakia and lichen planus: Candida biotypes in leukoplakia and lichen planus
55. Candida in patients with oral lichen planus
56. The frequency of Candida in oral lichen planus
57. Prevalence rate of Candida in the oral cavity of patients with oral lichen planus
58. Human papilloma virus in erosive oral lichen planus
59. Human herpes simplex-1 and papillomavirus type 16 homologous DNA sequences in normal, potentially malignant and malignant oral mucosa
60. Presence of HPV 16 sequences in oral lichen planus lesions
61. Involvement of cyclooxygenase-2 in interleukin-1 alpha-induced prostaglandin production by human periodontal ligament cells
62. Interleukin-1 regulation of prostaglandin E2 synthesis by the papillary collecting duct
63. Prognostic significance of prostaglandin E2 production in fresh tissues of head and neck cancer patients
64. Prognostic significance of prostaglandin E2 production by mononuclear cells and tumor cells in squamous cell carcinomas of the head and neck
65. Prostaglandins in squamous cell carcinoma of the larynx: Tumor and peritumor synthesis
66. Inhibition of cyclooxygenase-2 expression: An approach to preventing head and neck cancer